Adagrasib

Product

KRAS G12C inhibitor marketed as Krazati for non-small cell lung cancer

2 stories

Pancreatic Cancer Patients Face Significant Barriers Accessing Promising New Drug

Landmark Trial Reports Breakthrough Against Cancers Previously Deemed 'Undruggable'